ALISON TRIMBLE: Open Payments
NPI 1497474126 · PORT CHARLOTTE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,482 in 60 payments from 18 companies in 2025. Trend: 2023 $138 · 2024 $459 · 2025 $1,482
Food & beverage: $1,482
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $303 |
| Amgen Inc. | 13 | $193 |
| Lilly USA, LLC | 6 | $191 |
| AstraZeneca Pharmaceuticals LP | 2 | $144 |
| ABBVIE INC. | 5 | $129 |
| PFIZER INC. | 4 | $88 |
| SANOFI-AVENTIS U.S. LLC | 2 | $74 |
| Astellas Pharma US Inc | 3 | $70 |
| Esperion Therapeutics, Inc. | 3 | $58 |
| Corcept Therapeutics | 2 | $36 |
Products named: Ozempic, BREZTRI, ZEPBOUND, EVENITY, Rybelsus, OTEZLA, TZIELD, Veozah.
Industry payments across FL — which companies pay providers there.
